Sarah Nicol Lauder
7PUBLICATIONS
37CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Feb 02, 2026
Optimizing anti-PI3Kδ and anti-LAG-3 immunotherapy dosing regimens in a mouse model of triple-negative breast cancer improves outcome by removing treatment-related adverse events.Sarah Nicol Lauder, Ana Pires, Michelle Somerville
|Dec 15, 2023
Acquisition of suppressive function by conventional T cells limits antitumor immunity upon Treg depletion.Sarah K Whiteside, Francis M Grant, Giorgia Alvisi
|Aug 19, 2022
Treg-driven tumour control by PI3Kδ inhibition limits myeloid-derived suppressor cell expansion.Sarah N Lauder, Kathryn Smart, Valentina M T Bart
|Apr 07, 2021
Sequential targeting of PI3Kδ and LAG3 as an effective anti-cancer approach.Sarah N Lauder, Bart Vanhaesebroeck, Awen Gallimore
|Oct 23, 2020
Enhanced antitumor immunity through sequential targeting of PI3Kδ and LAG3.Sarah Nicol Lauder, Kathryn Smart, Veerle Kersemans
|Oct 07, 2020
Immune Remodeling of the Extracellular Matrix Drives Loss of Cancer Stem Cells and Tumor Rejection.Ana Pires, Alexander Greenshields-Watson, Emma Jones
Pageof 2
Frequent Collaborators
2 joint publications
Awen Gallimore
1 joint publications
David A Slatter
1 joint publications
Daniel Farewell
1 joint publications
Charles L Percy
1 joint publications
Sirpa Rannikko
1 joint publications
Salvatore Ferla
1 joint publications
Ginger L Milne
1 joint publications
Alastair W Poole
1 joint publications
Christopher P Thomas
1 joint publications
Philip R Taylor
